Project Grant 2614638
- Federal Grant Award Summary The University of Missouri System received a $411,539 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded May 15, 2026, with completion targeted for March 31, 2028. The award funds research investigating the functional role of extracellular vesicles (EVs)—nanoscale membrane-bound carriers—from the female reproductive tract during early...
- Federal Grant Award Summary The University of Missouri System received a $479,716 Project Grant from the National Science Foundation (NSF) Directorate for Engineering (CFDA 47.041) awarded on October 1, 2025, with an ultimate completion date of May 31, 2028. The project, "Bioionics: Probing Cellular Ionic Attributes Enabled by a Novel Soft Bio-Ionic Transistors," aims to develop innovative soft ionic transistor technology to measure and analyze ionic characteristics of biological cells...
- Federal Project Grant Award Summary The University of Missouri System received a $228,454 Project Grant from the National Science Foundation's Division of Environmental Biology (CFDA 47.074 – Biological Sciences) awarded June 1, 2025, with a completion date of May 31, 2028. This collaborative research initiative investigates the convergent evolution of inflated calyces and acylsugar chemical defenses in the tomatillo tribe (Physalideae). The project will produce a comprehensive phylogenetic tree...
- Federal Grant Award Summary The University of Missouri System received a $425,974 Project Grant award dated March 1, 2026, under the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on plant-derived steroidal biosynthetic pathways. The research program, scheduled for completion by December 31, 2030, aims to identify and characterize biosynthetic enzymes that convert plant sterols into...
- Federal Project Grant Award Summary The University of Missouri System received a $153,675 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded May 15, 2026, with completion targeted for April 30, 2028. The research investigates progesterone receptor signaling in oviductal ciliated epithelial cells and its role in preserving reproductive longevity and delaying...
- Federal Grant Award Summary The University of Missouri System received a $558,358 Project Grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084), awarded May 15, 2026, with completion targeted for April 30, 2027. The award funds a conference designed to enhance institutional capacity across the research ecosystem by convening leadership from NSF Emerging Partnerships and Innovation Institutions (EPIIC) awardee institutions. The...
- Federal Project Grant Award Summary The University of Missouri System received a $471,311 Project Grant award, effective September 1, 2025 through August 31, 2028, from the National Science Foundation's Division of Molecular and Cellular Biosciences under the Biological Sciences program (CFDA 47.074). The award supports fundamental research analyzing Barbara McClintock's discovery of the "tiny fragment" chromosome and its "X component," which catalyzes dramatic genomic...
- Federal Project Grant Award Summary The University of Missouri System received a $418,822 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 5, 2026, with completion targeted for February 28, 2031. This award supports investigator-initiated basic biomedical research focused on advancing mechanistic understanding of membrane interfaces—specifically, the discovery and...
- Federal Grant Award Summary Carnegie Mellon University's Office of Sponsored Programs received a $575,000 CAREER Project Grant from the National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems under the Engineering program (CFDA 47.041). The award, dated June 15, 2026, funds a five-year research initiative through May 31, 2031, to develop multiscale computational models of blood flow and oxygen transport in the human placenta. The project...
- Federal Grant Award Summary The University of Missouri System received a $166,310 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) for the period September 1, 2025 through August 31, 2027. The research project, titled "Intergenerational Socioeconomic and Health Effects of Family Support Programs," examines the long-term impacts of welfare program withdrawal...
The University of Missouri System received $165,787 in federal funding from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084), with an award date of October 1, 2025 and completion deadline of October 31, 2026. This Project Grant supports development of an innovative platform technology for modeling pharmaceutical transport across the placental barrier. The system integrates three-dimensional (3D) cell culture, sensing, and imaging capabilities to enable quantitative analysis of how pharmaceutical compounds permeate the placental barrier and translocate into fetal blood circulation. The platform replicates physiological matrix mechanics, hemodynamics, and placental barrier permeability to facilitate high-throughput screening and rapid data collection across a broader range of pharmaceutical compounds than current methodologies permit. The deliverable represents a paradigm shift in placental pharmaceutical transport research through personalized diagnostic capability using each expectant mother's stem cells to enhance accuracy in testing compound transport rates and establishing safe exposure levels. Upon successful completion, the platform is anticipated to provide an economical and physiologically relevant tool that reduces testing costs, enables real-time monitoring, and demonstrates commercial market potential. The technology addresses critical understanding of metabolic and inflammatory processes in the placenta while laying a foundation for future commercialization and clinical application.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $165.8k | 3/6/26 |